ÂÜÀòÂÒÂ×

Kimberly Lindstrom, PhD is an experienced professional who has held various regulatory and scientific roles in biopharmaceutical companies such as MyoKardia, Gilead Sciences, and Day One Biopharmaceuticals. With a strong academic background in molecular and cellular biology, Kimberly has also worked as a postdoctoral fellow and graduate student in renowned research institutions such as the University of Washington and Fred Hutchinson Cancer Research Center. Additionally, Kimberly has experience as a regulatory consultant, scientific content editor, and has interned in various labs during their educational years.